Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia
Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of the vaginal micronized progesterone
and Levonorgestrel-releasing Intrauterine System for treatment of non-atypical endometrial
hyperplasia in premenopausal women.